New Atlas

Bi-monthly injection prevents HIV infection, early trial data suggests

A large-scale phase 2b/3 trial testing the efficacy of a novel drug designed to prevent HIV infection has been cut short due to a combination of positive early data and disruptions caused by the COVID ...
Yahoo Finance

Bi-monthly injection blocks HIV in study from J&J and GSK

Nov 3 (Reuters) - A long-acting two-drug injection given once every eight weeks worked as well as three daily pills in suppressing HIV, the virus that causes AIDS, according to a clinical trial backed ...
Mena FN

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance Of The IND Application For The Innovative Bi-Weekly GLP-1RA GZR18 Injection, Bofanglutide, With Chronic Weight Management ...

Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087), is pleased to announce that the Food and Drug Administration (" FDA ") has cleared the Investigational New Drug (IND) ...
manilatimes

Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management ...

BEIJING and BRIDGEWATER, N.J., Dec. 18, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087.SH), is pleased to announce that the Food and Drug Administration (" ...